Patent and Exclusivity Expirations Report

Report generated for the week of 2024-12-30 by Unibest Digital Center. Current analysis scope only include the US FDA.

Summary of Expirations

This week, there is 1 drug in the patent and exclusivity list. It is:
- BAUSCH AND LOMB INC's VYZULTA, containing active ingredient LATANOPROSTENE BUNOD

Patents Expiring This Week

LATANOPROSTENE BUNOD - SOLUTION/DROPS;OPHTHALMIC - VYZULTA

From BAUSCH AND LOMB INC; for reducing ocular hypertension or treat open-angle glaucoma.

0.024%

Approved in Nov 2, 2017, used as Reference Listed Drug and Reference Standard

There are 2 future patent(s) for this application. The earliest expires on 2025-10-03, and the latest expires on 2029-02-21.

Patent No	Patent Use Code	Patent Use Definition	Patent Expiration Date	Patent Title
7629345	U-2144	REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION	2025-01-05	Prostaglandin derivatives
7910767	U-2144	REDUCTION OF INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION	2025-01-05	Prostaglandin derivatives

Exclusivities Expiring This Week

No expirations this week.